Europe Cancer Chemotherapy Market
Buy Now Request Sample Explore
Home › Report Store › Life Sciences  › Europe Cancer Chemotherapy Market

Europe Cancer Chemotherapy Market Outlook (2021–2031)

The Europe Cancer Chemotherapy Market size is expected to reach US$ 23,140.5 million by 2031 from US$ 11,680.2 million in 2024. The market is estimated to record a CAGR of 10.4% from 2025 to 2031.

Report Coverage
  • Therapy Type: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Other Therapy Type
  • Indication: Blood Cancer, Lung Cancer, Breast Cancer, Colorectum Cancer, Prostate Cancer, Stomach Cancer, Cervical Cancer, Liver and Intrahepatic Bile Duct Cancer, Thyroid Cancer, Other Indications
  • End User: Hospital Pharmacies, Retail Pharmacies, Online Stores
US$ 11,680.2 Mn Market size in 2024
US$ 23,140.5 Mn Market Size by 2031
10.4% CAGR, 2025 - 2031
2025-2031 Forecast Period

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Europe Cancer Chemotherapy Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Europe Cancer Chemotherapy Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Europe Cancer Chemotherapy Market Regional Analysis

6.2 Europe Cancer Chemotherapy Market Revenue 2021-2031 (US$ Million)
6.3 Europe Cancer Chemotherapy Market Forecast Analysis

7. Europe Cancer Chemotherapy Market Analysis – by Therapy Type

7.1 Alkylating Agents
  • 7.1.1 Overview
  • 7.1.2 Alkylating Agents: Europe Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Antimetabolites
  • 7.2.1 Overview
  • 7.2.2 Antimetabolites: Europe Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Anti-Tumor Antibiotics
  • 7.3.1 Overview
  • 7.3.2 Anti-Tumor Antibiotics: Europe Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Topoisomerase Inhibitors
  • 7.4.1 Overview
  • 7.4.2 Topoisomerase Inhibitors: Europe Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Mitotic Inhibitors
  • 7.5.1 Overview
  • 7.5.2 Mitotic Inhibitors: Europe Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.6 Other Therapy Type
  • 7.6.1 Overview
  • 7.6.2 Other Therapy Type: Europe Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

8. Europe Cancer Chemotherapy Market Analysis – by Indication

8.1 Blood Cancer
  • 8.1.1 Overview
  • 8.1.2 Blood Cancer: Europe Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Lung Cancer
  • 8.2.1 Overview
  • 8.2.2 Lung Cancer: Europe Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Breast Cancer
  • 8.3.1 Overview
  • 8.3.2 Breast Cancer: Europe Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Colorectum Cancer
  • 8.4.1 Overview
  • 8.4.2 Colorectum Cancer: Europe Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Prostate Cancer
  • 8.5.1 Overview
  • 8.5.2 Prostate Cancer: Europe Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.6 Stomach Cancer
  • 8.6.1 Overview
  • 8.6.2 Stomach Cancer: Europe Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.7 Cervical Cancer
  • 8.7.1 Overview
  • 8.7.2 Cervical Cancer: Europe Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.8 Liver and Intrahepatic Bile Duct Cancer
  • 8.8.1 Overview
  • 8.8.2 Liver and Intrahepatic Bile Duct Cancer: Europe Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.9 Thyroid Cancer
  • 8.9.1 Overview
  • 8.9.2 Thyroid Cancer: Europe Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.10 Other Indications
  • 8.10.1 Overview
  • 8.10.2 Other Indications: Europe Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

9. Europe Cancer Chemotherapy Market Analysis – by End User

9.1 Hospital Pharmacies
  • 9.1.1 Overview
  • 9.1.2 Hospital Pharmacies: Europe Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Retail Pharmacies
  • 9.2.1 Overview
  • 9.2.2 Retail Pharmacies: Europe Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Online Stores
  • 9.3.1 Overview
  • 9.3.2 Online Stores: Europe Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

10. Europe Cancer Chemotherapy Market – Europe Analysis

10.1 Overview

10.2 Europe
  • 10.2.1 Europe Cancer Chemotherapy Market Breakdown, by Key Country, 2025 and 2031 (%)
  • 10.2.1.1 Europe Cancer Chemotherapy Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 Belgium: Europe Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.1.1 Belgium: Europe Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.1.2 Belgium: Europe Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.1.3 Belgium: Europe Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.2 Austria: Europe Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.2.1 Austria: Europe Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.2.2 Austria: Europe Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.2.3 Austria: Europe Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.3 Finland: Europe Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.3.1 Finland: Europe Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.3.2 Finland: Europe Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.3.3 Finland: Europe Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.4 Denmark: Europe Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.4.1 Denmark: Europe Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.4.2 Denmark: Europe Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.4.3 Denmark: Europe Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.5 Greece: Europe Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.5.1 Greece: Europe Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.5.2 Greece: Europe Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.5.3 Greece: Europe Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.6 Poland: Europe Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.6.1 Poland: Europe Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.6.2 Poland: Europe Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.6.3 Poland: Europe Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.7 Romania: Europe Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.7.1 Romania: Europe Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.7.2 Romania: Europe Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.7.3 Romania: Europe Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.8 Russia: Europe Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.8.1 Russia: Europe Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.8.2 Russia: Europe Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.8.3 Russia: Europe Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.9 Ukraine: Europe Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.9.1 Ukraine: Europe Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.9.2 Ukraine: Europe Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.9.3 Ukraine: Europe Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.10 Czech Republic: Europe Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.10.1 Czech Republic: Europe Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.10.2 Czech Republic: Europe Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.10.3 Czech Republic: Europe Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.11 Slovakia: Europe Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.11.1 Slovakia: Europe Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.11.2 Slovakia: Europe Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.11.3 Slovakia: Europe Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.12 Bulgaria: Europe Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.12.1 Bulgaria: Europe Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.12.2 Bulgaria: Europe Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.12.3 Bulgaria: Europe Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.13 Italy: Europe Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.13.1 Italy: Europe Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.13.2 Italy: Europe Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.13.3 Italy: Europe Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.14 Luxembourg: Europe Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.14.1 Luxembourg: Europe Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.14.2 Luxembourg: Europe Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.14.3 Luxembourg: Europe Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.15 Germany: Europe Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.15.1 Germany: Europe Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.15.2 Germany: Europe Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.15.3 Germany: Europe Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.16 Switzerland: Europe Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.16.1 Switzerland: Europe Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.16.2 Switzerland: Europe Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.16.3 Switzerland: Europe Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.17 France: Europe Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.17.1 France: Europe Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.17.2 France: Europe Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.17.3 France: Europe Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.18 Netherlands: Europe Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.18.1 Netherlands: Europe Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.18.2 Netherlands: Europe Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.18.3 Netherlands: Europe Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.19 Norway: Europe Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.19.1 Norway: Europe Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.19.2 Norway: Europe Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.19.3 Norway: Europe Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.20 Portugal: Europe Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.20.1 Portugal: Europe Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.20.2 Portugal: Europe Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.20.3 Portugal: Europe Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.21 Spain: Europe Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.21.1 Spain: Europe Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.21.2 Spain: Europe Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.21.3 Spain: Europe Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.22 Sweden: Europe Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.22.1 Sweden: Europe Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.22.2 Sweden: Europe Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.22.3 Sweden: Europe Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.23 United Kingdom: Europe Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.23.1 United Kingdom: Europe Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.23.2 United Kingdom: Europe Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.23.3 United Kingdom: Europe Cancer Chemotherapy Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 Astellas Pharma Inc
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Eli Lilly and Co
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Novartis AG
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Merck KGaA
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Johnson & Johnson
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 AstraZeneca
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Pfizer Inc
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Bristol Myers Squibb
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 F. Hoffmann-La Roche Ltd
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 AbbVie
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

Access the Full E Market Report

Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.

Download Sample Request Customization
Access the full E Market Report
293 pages PDF & Excel | 2026-02-19
Download Sample Customization